SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tenchusatsu who wrote (1576286)12/10/2025 6:25:49 PM
From: Maple MAGA 1 Recommendation

Recommended By
longz

  Read Replies (1) of 1579480
 
Pfizer is a criminal organization, if you don't understand that you are either a criminal or criminally stupid.
  • It is impossible to list every Pfizer court case because the company has thousands of lawsuits across many decades and countries.

  • Public databases show dozens of government enforcement actions and many billions in penalties, but these still do not cover all private lawsuits or international cases.
Major Historical Pfizer Cases
  • 2009: Pfizer paid $2.3 billion for criminal and civil allegations involving illegal off-label marketing of Bextra and several other drugs.

  • 2004: Pfizer (via Warner-Lambert) paid $430 million for off-label marketing of Neurontin.

  • 2004–2014: Neurontin civil litigation resulted in about $945 million total in settlements.

  • 2000s: Additional Bextra and Celebrex marketing cases were included in the 2009 DOJ settlement.
Securities and Investor Cases
  • Shareholder lawsuits were filed claiming Pfizer failed to disclose the extent of illegal marketing practices leading up to the 2009 settlement.

  • These securities class actions occurred in U.S. federal court and involved allegations of misleading investors.
Co-Pay Assistance / Anti-Kickback Case
  • Pfizer sued HHS seeking approval for a co-pay assistance program for its heart drug tafamidis.

  • Courts ruled against Pfizer, stating the program would violate the Anti-Kickback Statute.

  • The Second Circuit upheld the decision, and the Supreme Court declined to review it.
COVID-19 Vaccine-Related Litigation
  • Texas sued Pfizer claiming the company misrepresented vaccine effectiveness; a federal judge dismissed the case but Texas appealed, and litigation continues.

  • Kansas filed a similar lawsuit alleging Pfizer misled residents about vaccine risks and benefits; the case remains active.

  • Experts have widely criticized the scientific basis of these state lawsuits.
Patent Litigation Related to COVID Vaccines
  • Moderna sued Pfizer and BioNTech in the U.S. and Europe claiming their COVID-19 vaccine infringed Moderna’s mRNA patents; litigation is ongoing in multiple jurisdictions.

  • UK courts ruled that at least one Moderna patent was valid and infringed, allowing Moderna to seek damages for post-2022 sales of Comirnaty.

  • Alnylam sued Pfizer and BioNTech over lipid nanoparticle (LNP) patents; in 2025 Alnylam dropped its U.S. case after an unfavorable claim-construction ruling but is considering appeal.
Other Recent Pfizer-Related Cases
  • Seagen (owned by Pfizer) sued Daiichi Sankyo over the cancer drug Enhertu; an early jury verdict for Seagen was overturned by the Federal Circuit, which found the patent invalid.

  • Pfizer filed an antitrust lawsuit against Metsera, its controlling stockholders, and Novo Nordisk involving competition in the obesity-drug market; litigation is in early stages.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News